Insulin aspart, recombinant Subcutaneous and Neomycin Oral Solution
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Neomycin Oral Solution and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: neomycin
Brand name: Neo-Fradin, Neo-Tab, Mycifradin
Synonyms: Neomycin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Neomycin Sulfate
- Insulin aspart, recombinant Subcutaneous-Neomycin Sulfate topical
- Insulin aspart, recombinant Subcutaneous-Neomycin Tablets
- Insulin aspart, recombinant Subcutaneous-Neomycin Topical
- Insulin aspart, recombinant Subcutaneous-Neomycin, Colistin, Hydrocortisone, and Thonzonium
- Insulin aspart, recombinant Subcutaneous-Neomycin, polymyxin b, and bacitracin Topical
- Neomycin Oral Solution-Insulin degludec
- Neomycin Oral Solution-Insulin Degludec (U-100) Prefilled Pens
- Neomycin Oral Solution-Insulin Degludec (U-100) Vials
- Neomycin Oral Solution-Insulin Degludec (U-200) Prefilled Pens
- Neomycin Oral Solution-Insulin degludec and liraglutide
- Neomycin Oral Solution-Insulin degludec and liraglutide Subcutaneous